Potentiating Effect of Adenosine on Other Inhibitors of Platelet Aggregation

Summary

Adenosine was rapidly incorporated into human platelets, and the inhibitory effect of adenosine on platelet aggregation was correlated with the incorporation process. Adenosine potentiated the inhibitory action of other inhibitors, such as dipyridamole, prostaglandin E₁ and Y-3642. The inhibition of aggregation was associated with the preservation of platelet adenine nucleotides and the prevention of ADP release. On the other hand, the radioactive adenine nucleotide pattern of platelets was not substantially affected by inhibitors. The relation of inhibition of aggregation with ADP release was discussed.

• References

• 1 Ball G, Fulwood M, Ireland D. M, Yates P. Effect of some inhibitors of platelet aggregation on platelet nucleotides. Biochem. J 114: 669 1969;
• 2 Born G. V. R, Cross M. J. The aggregation of blood platelets. J. Physiol 168: 178 1963;
• 3 Born G. V. R. Strong inhibition by 2-chloradenosine of the aggregation of blood platelets by adenosine diphosphate. Nature (Lond) 202: 95 1964;
• 4 Born G. V.R, Mills D. C. B. Potentiation of the inhibitory effect of adenosine on platelet aggregation by drugs that prevent its uptake. J. Physiol 202: 41 1969; (abst.)
• 5 Brecher G, Cronkite E. P. Morphology and enumeration of human blood platelets. J. appl. Physiol 03: 365 1950;
• 6 O’Brien J. R, Heywood J. B, Heady J. A. The quantitation of platelet aggregation induced by four compounds: a study in relation to myocardial infraction. Thrombos. Diathes. haemorrh. (Stuttg) 16: 752 1966;
• 7 Danta G. Platelet adhesiveness in cerebrovascular disease. Atherosclerosis 11: 223 1970;
• 8 Haslam R. J. Pole of adenosine diphosphate in the aggregation of human blood-platelets by thrombin and by fatty acids. Nature (Lond) 202: 765 1964;
• 9 Hirsh J, McBride J. A. Increased platelet adhesiveness in recurrent venous thrombosis and pulmonary embolism. Brit. Med. J 02: 797 1965;
• 10 Holmsen H, Holmsen I, Bernhardsen A. Micro determination of adenosine diphosphate and adenosine triphosphate in plasma with the firefly luciferase system. Analyt. Biochem 17: 456 1966;
• 11 Hovig T. The role of platelets in thrombosis. Thrombos. Diathes. haemorrh Suppl.42 137 1971;
• 12 Hume M. Platelet adhesiveness and other coagulation factors in thrombophlebitis. Surgery 59: 110 1966;
• 13 Michal F, Maguire M. H, Gough G. 2-Methylthioadenosine-5’-phosphate : a specific inhibitor of platelet aggregation. Nature (Lond) 222: 1073 1969;
• 14 Murakami M, Odake K. Adenine nucleotide metabolism of human platelets. Thin-layer chromatographic separation of labelled adenine nucleotides. Thrombos. Diathes. haemorrh. (Stuttg) 25: 223 1971;
• 15 Murakami M, Takase M, Yoshino K, Odake K. Relationship of adenosine-3’ 5’-monophosphate to other adenine nucleotides in human platelets. Biochem. Biophys. Res. Commun 44: 797 1971;
• 16 Philp R. B. Species-dependent inhibition of platelet aggregation by adenosine and dipyridamole: paradoxical potentiation in the rat: Thrombos. Diathes. haemorrh. (Stuttg) 23: 129 1970;
• 17 Philp R. B, Lemieux J. P. V. Interaction of dipyridamole and adenosine on platelet aggregation. Nature (Lond) 221: 1162 1969;
• 18 Rozenberg M. G, Holmsen H. Adenine nucleotide metabolism of blood platelets. II. Uptake of adenosine and inhibition of ADP-induced platelet aggregation. Biochim. biophys. Acta 155: 342 1968;
• 19 Rozeriberg M. G, Ledwidge G. M, Wilclcen D. E.L, McKeon M. The inhibition of adenosine phosphorylation in platelets by dipyridamole. J. Lab. clin. Med 77: 88 1971;
• 20 Salzman E. W, Harris W. H, De Sanctis E. W. Reduction in venous thromboembolism by agents affecting platelet function. New Engl. J. Med 254: 1287 1971;
• 21 Sullivan J. M, Harken D. E, Gorlin R. Pharmacologic control of thromboembolic complica tions of cardiac-valve replacement. New Engl. J. Med 284: 1391 1971;
• 22 Weily H. S, Genton E. Effect of sulfinpyrazone therapy. Altered platelet function in patients with prosthetic mitral valve. Circulation 42: 967 1970;